litlas
Log inCreate account

Philip Seeman

Active 1963–2018

132
Papers
36,117
Citations
98
h-index
130
i10-index

Citations

Citations per year for Philip Seeman1967: 3 citations1968: 6 citations1969: 30 citations1970: 22 citations1971: 37 citations1972: 42 citations1973: 39 citations1974: 59 citations1975: 63 citations1976: 70 citations1977: 118 citations1978: 104 citations1979: 114 citations1980: 115 citations1981: 113 citations1982: 84 citations1983: 107 citations1984: 94 citations1985: 100 citations1986: 88 citations1987: 144 citations1988: 90 citations1989: 122 citations1990: 101 citations1991: 175 citations1992: 209 citations1993: 226 citations1994: 176 citations1995: 176 citations1996: 158 citations1997: 226 citations1998: 170 citations1999: 227 citations2000: 215 citations2001: 227 citations2002: 214 citations2003: 243 citations2004: 199 citations2005: 229 citations2006: 263 citations2007: 239 citations2008: 215 citations2009: 202 citations2010: 250 citations2011: 184 citations2012: 178 citations2013: 208 citations2014: 134 citations2015: 147 citations2016: 146 citations2017: 135 citations2018: 113 citations2019: 387 citations2020: 313 citations2021: 263 citations2022: 184 citations2023: 122 citations2024: 183 citations2025: 80 citations2026: 2 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,754 citing papers, 36.6% of this breakdownCanada: 677 citing papers, 9% of this breakdownUnited Kingdom: 651 citing papers, 8.6% of this breakdownGermany: 375 citing papers, 5% of this breakdownItaly: 292 citing papers, 3.9% of this breakdownFrance: 289 citing papers, 3.8% of this breakdownJapan: 245 citing papers, 3.3% of this breakdownSweden: 222 citing papers, 2.9% of this breakdownChina: 184 citing papers, 2.4% of this breakdownAustralia: 183 citing papers, 2.4% of this breakdownNetherlands: 148 citing papers, 2% of this breakdownSpain: 140 citing papers, 1.9% of this breakdown
0%36.6%Other 18.2%

Institutions

Fields

  • Medicine35.9%
  • Neuroscience32.7%
  • Biochemistry, Genetics and Molecular Biology22.6%
  • Psychology2.8%
  • Computer Science1.1%
  • Chemistry0.9%
  • Other4%

Topics

  • Neurotransmitter Receptor Influence on Behavior12.2%
  • Receptor Mechanisms and Signaling8.5%
  • Neuroscience and Neuropharmacology Research8%
  • Schizophrenia research and treatment5.9%
  • Neurological disorders and treatments2.5%
  • Parkinson's Disease Mechanisms and Treatments2.3%
  • Other60.6%

Coauthors

All papers

Open in search
  1. Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose

    Authors: Philip Seeman - Translational Psychiatry 2016 cited by 172

  2. Does Fast Dissociation From the Dopamine D2Receptor Explain the Action of Atypical Antipsychotics?: A New Hypothesis

    Authors: Shitij Kapur, Philip Seeman - American Journal of Psychiatry 2001 cited by 1,129

  3. Clozapine, a Fast-Off-D2 Antipsychotic

    Authors: Philip Seeman - ACS Chemical Neuroscience 2013 cited by 129

  4. NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D2 and serotonin 5-HT2 receptors—implications for models of schizophrenia

    Authors: Shitij Kapur, Philip Seeman - Molecular Psychiatry 2002 cited by 462

  5. Antipsychotic drug doses and neuroleptic/dopamine receptors

    Authors: Philip Seeman, T. Lee, M. Chau-Wong, Kwok-Ying Wong - Nature 1976 cited by 1,635

  6. Atypical Antipsychotics: Mechanism of Action

    Authors: Philip Seeman - The Canadian Journal of Psychiatry 2002 cited by 901

  7. Dopamine receptors and the dopamine hypothesis of schizophrenia

    Authors: Philip Seeman - Synapse 1987 cited by 876

  8. Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

    Authors: Philip Seeman, Teresa Lee - Science 1975 cited by 871

  9. Increased dopamine D 2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study

    Authors: S. Silvestri, Mary V. Seeman, Juan-Carlos Negrete, Sylvain Houle, Chekkera Shammi, G. Remington, Shitij Kapur, Robert B. Zipursky, Alan A. Wilson, Bruce K. Christensen, Philip Seeman - Psychopharmacology 2000 cited by 309

  10. “Breakthrough” Dopamine Supersensitivity during Ongoing Antipsychotic Treatment Leads to Treatment Failure over Time

    Authors: Anne‐Noël Samaha, Philip Seeman, Jane Stewart, Heshmat Rajabi, Shitij Kapur - Journal of Neuroscience 2007 cited by 262

  11. Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors

    Authors: Philip Seeman - Synapse 2015 cited by 154

  12. Radioreceptor Binding Profile of the Atypical Antipsychotic Olanzapine

    Authors: Frank P. Bymaster, David O. Calligaro, Julie F. Falcone, Richard D Marsh, Nicholas Moore, N.C. Tye, Philip Seeman, David T. Wong - Neuropsychopharmacology 1996 cited by 1,070

  13. Schizophrenia: More dopamine, more D 2 receptors

    Authors: Philip Seeman, Shitij Kapur - National Academy of Sciences, Proceedings of the National Academy of Sciences 2000 cited by 273

  14. Schizophrenia and dopamine receptors

    Authors: Philip Seeman - European Neuropsychopharmacology 2013 cited by 121

  15. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1

    Authors: Roger K. Sunahara, Hong‐Chang Guan, Brian F. O’Dowd, Philip Seeman, Lisanne G. Laurier, Gordon Ng, Susan R. George, Joeseph Torchia, Hubert H.M. Van Tol, Hyman B. Niznik - Nature 1991 cited by 1,166

  16. The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia

    Authors: Toni D. Wolinsky, Chad J. Swanson, Kelli E. Smith, Hai Zhong, Beth Borowsky, Philip Seeman, T. A. Branchek, Christophe Gerald - Genes Brain & Behavior 2006 cited by 244

  17. Alzheimer's disease: β‐amyloid plaque formation in human brain

    Authors: Philip Seeman, Neil Seeman - Synapse 2011 cited by 94

  18. The Dopamine D1-D2 Receptor Heteromer Localizes in Dynorphin/Enkephalin Neurons

    Authors: Melissa L. Perreault, Ahmed Hasbi, Mohammed Alijaniaram, Theresa Fan, George Varghese, Paul Fletcher, Philip Seeman, Brian F. O’Dowd, Susan R. George - Journal of Biological Chemistry 2010 cited by 186

  19. STRUCTURE OF MEMBRANE HOLES IN OSMOTIC AND SAPONIN HEMOLYSIS

    Authors: Philip Seeman, D. Cheng, G. H. Iles - The Journal of Cell Biology 1973 cited by 186

  20. Brain receptors for antipsychotic drugs and dopamine: direct binding assays.

    Authors: Philip Seeman, M. Chau-Wong, J. L. Tedesco, Kwok-Ying Wong - National Academy of Sciences, Proceedings of the National Academy of Sciences 1975 cited by 702

  21. Targeting the dopamine D2receptor in schizophrenia

    Authors: Philip Seeman - Expert Opinion on Therapeutic Targets 2006 cited by 302

  22. Antipsychotic drugs which elicit little or no Parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors

    Authors: Philip Seeman, Teresa Tallerico - Molecular Psychiatry 1998 cited by 299

  23. Atypical Neuroleptics Have Low Affinity for Dopamine D2 Receptors or Are Selective for D4 Receptors

    Authors: Philip Seeman - Neuropsychopharmacology 1997 cited by 235

  24. Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics

    Authors: Philip Seeman, Françoise Ko, Teresa Tallerico - Molecular Psychiatry 2005 cited by 201